SARS-CoV-2 Infects Microglia, the Immune Cells of the Brain, Affecting Long-Term Cerebrum Health

Medical News: Microglia are the immune cells of the brain that constantly monitor the environment for infections, damage, or unwanted substances. These cells play a critical role in protecting the brain from harmful invaders and are essential for maintaining normal brain function. Unlike neurons, which do not replicate, microglia can proliferate, particularly in response to injury or infection. They are present in both the brain and spinal cord, where they help to regulate inflammation, remove dead cells, and maintain neural connections.


SARS-CoV-2 Infects Microglia, the Immune Cells of the Brain, Affecting Long-Term Cerebrum Health

Microglia are highly adaptable and can change their shape and function depending on the needs of the brain. In their normal state, they have long branches that extend in multiple directions, allowing them to patrol the brain effectively. However, during chronic inflammation or immune challenges, these branches retract, and the microglia become round and more active in responding to threats. This transformation can have significant implications for brain health, especially when prolonged or uncontrolled.
 
SARS-CoV-2 and Its Impact on the Central Nervous System
Since the emergence of SARS-CoV-2, researchers have been investigating how this virus affects the brain. Studies have shown that the virus can reach the central nervous system through various pathways, including the bloodstream and the olfactory nerves. However, whether SARS-CoV-2 directly infects brain cells, particularly microglia, has been a topic of ongoing investigation.
 
This Medical News report highlights key findings from a recent study on SARS-CoV-2 infection in microglia. Researchers from multiple institutions, including The University of Hong Kong-China, University of Manchester-UK, and Charité – Universitätsmedizin Berlin-Germany, have conducted extensive research to determine the virus’s impact on these crucial brain cells. Their findings shed new light on the complex relationship between SARS-CoV-2 and microglia, offering insights into the long-term neurological effects of COVID-19.
 
Key Findings from the Study
-Microglia Activation in Response to SARS-CoV-2
The study found that even without direct infection, SARS-CoV-2 triggers significant changes in microglia. When exposed to the virus, microglia show signs of activation, characterized by increased inflammation and heightened immune responses. This activation can lead to prolonged neuroinflammation, which may contribute to cognitive and neurological complications seen in some COVID-19 patients.
 
-Evidence of Viral Entry and Replication
One of the major questions in this research was whether SARS-CoV-2 can infect microglia directly. The researchers observed that while viral RNA and proteins were detected in microglial cells, the extent of actual viral replication remains unclear. Some models of microglia showed signs of viral replication, whereas others did not, s uggesting that the infection process might depend on specific conditions or cell types.
 
-Microglia and Phagocytosis of Infected Neurons
The study also discovered that microglia actively engulf and clear infected neurons and astrocytes (another type of brain cell). This phagocytic activity, while essential for removing damaged cells, could also contribute to excessive loss of neurons and synaptic connections, potentially leading to long-term neurological symptoms such as memory loss, cognitive decline, and psychiatric disorders.
 
The Role of Microglia in Long COVID and Neurological Symptoms
One of the most concerning aspects of COVID-19 is its long-term impact on brain function, often referred to as "long COVID." Patients with long COVID frequently report brain fog, memory problems, and mental fatigue. This study provides evidence that microglial activation could be a key driver of these symptoms. When microglia remain in an activated state for extended periods, they may continue to release inflammatory molecules that disrupt normal brain function.
 
Furthermore, researchers found that microglia might also contribute to the disruption of the blood-brain barrier, allowing harmful substances and immune cells to enter the brain. This increased permeability could exacerbate inflammation and further damage neural circuits, compounding the neurological effects of SARS-CoV-2 infection.
 
Experimental Models Used in the Study
To explore the effects of SARS-CoV-2 on microglia, the researchers used a combination of laboratory models, including:
 
-Human microglia cell lines (HMC3): These cells provided insight into how SARS-CoV-2 interacts with microglia at a molecular level.
 
-Induced pluripotent stem cell (iPSC)-derived microglia: These models allowed scientists to examine the behavior of microglia derived from human stem cells, mimicking real-life brain conditions more closely.
 
-Rodent and non-human primate models: These animal studies helped researchers understand how microglia respond to infection in a whole-brain environment.
 
-Post-mortem brain tissue from COVID-19 patients: By analyzing brain tissues from individuals who had COVID-19, researchers identified patterns of microglial activation and inflammation associated with SARS-CoV-2.
 
Potential Implications for Future Treatments
Given the role of microglia in regulating brain inflammation, targeting these cells may offer a promising approach to managing the neurological effects of COVID-19. Researchers suggest that anti-inflammatory therapies aimed at calming overactive microglia could help prevent or reduce long-term neurological complications.
 
Several potential therapeutic strategies include:
-Modulating immune responses: Drugs that suppress excessive inflammation in microglia may help protect brain health.
 
-Enhancing microglial function: Encouraging microglia to efficiently clear viral debris while minimizing damage to healthy neurons could be beneficial.
 
-Restoring blood-brain barrier integrity: Strengthening the protective barrier around the brain may reduce inflammation and prevent harmful substances from entering the central nervous system.
 
Study Limitations and Future Research Directions
Despite the groundbreaking findings, researchers acknowledge several limitations in the study. The extent to which SARS-CoV-2 directly infects microglia remains unclear, and more studies are needed to confirm whether viral replication occurs in these cells. Additionally, differences in experimental models, including variations in microglial cell types and viral strains, may account for some conflicting results.
 
Future research should focus on:
-Longitudinal studies on COVID-19 survivors: Tracking patients over time to assess ongoing changes in microglial function.
 
-Advanced imaging techniques: Utilizing cutting-edge technology to observe microglia in living patients.
 
-Development of targeted treatments: Investigating drugs that specifically address microglial dysfunction in COVID-19-related neurological conditions.
 
Conclusion
The study provides compelling evidence that SARS-CoV-2 can significantly alter microglial function, even if direct infection is not always observed. By triggering prolonged activation of these immune cells, the virus may contribute to the neurological symptoms associated with COVID-19, including cognitive decline, mental fog, and neuropsychiatric disorders. The findings highlight the need for continued research to better understand the virus’s impact on the brain and to develop targeted therapies that can mitigate long-term neurological consequences.
 
The study findings were published in the peer-reviewed journal: Brain Behavior and Immunity Health
https://www.sciencedirect.com/science/article/pii/S2666354624001662
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/covid-19-alters-brain-glucose-metabolism
 
https://www.thailandmedical.news/news/enlarged-choroid-plexus-in-long-covid-linked-to-cognitive-and-brain-changes
 
https://www.thailandmedical.news/news/impact-of-covid-19-on-blood-brain-barrier-and-alzheimer-risk
 
https://www.thailandmedical.news/news/covid-19-causes-reversible-cerebral-vasoconstriction-syndrome-that-lasts-for-months
 
https://www.thailandmedical.news/news/french-scientists-find-that-sars-cov-2-can-replicate-and-persist-in-the-brainstem-for-lengthy-periods
 
https://www.thailandmedical.news/news/covid-19-s-hidden-impact-enlarged-brain-structures-in-some-patients
 
https://www.thailandmedical.news/articles/coronavirus